美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

百济神州

230.98

+2.841.24%

盘后：229.75-1.0150-0.44%17:21 EDT

成交量：51.99万

成交额：1.20亿

市值：248.81亿

市盈率：-37.72

高：234.15

开：229.30

低：227.40

收：228.14

数据加载中...

总览公司新闻公告

【港股异动丨百济神州逆势高开超5%再创逾2年新高，预计2025年实现经营利润为正】百济神州(6160.HK)逆势高开5.2%，报170港元，股价创2023年1月以来新高。百济神州昨晚公布2024年度财报，按美国公认会计准(GAAP)，总收入38.1亿美元，同比增加55%，主要受惠百悦泽在美国和欧洲的销售额增长。GAAP经营亏损由12.08亿美元，收窄至5.68亿美元；实现全年非GAAP经营利润4,536万美元。2025年，收入指引介乎49亿至53亿美元；GAAP经营费用41亿至44亿美元；GAAP毛利率将处于80%-90%的中位区间。同时，重申GAAP经营利润为正，且经营活动产生现金流为正。 TD Cowen维持百济神州买入评级，并将美股目标价从260美元上调至334美元。

百济神州发布2024年度业绩快报营业总收入272.14亿元同比增加56.2%

百济神州，正在走安进曾经的路

百济神州预计2025年实现经营利润为正创新药企回暖在即？

21世纪经济报道

异动解读 | 百济神州核心产品表现出色公司2025年营收利润预期向好推动股价大涨6%

百济神州2024年度亏损近50亿元美国市场首次贡献超50%收入

每日经济新闻

百济神州(688235.SH)2024年度营收上升56.2%至272.14亿元，产品销售增长

正在向盈利冲刺的百济神州，2024年经调整的营业利润提前转正

百济神州去年净亏收窄至近50亿元，首次给出财务指引料今年经营利润转正

百济神州2024年净亏损近50亿元同比减亏25.87%

每日经济新闻

百济神州(06160)：Shalini Sharp获委任为董事会审计委员会主席

异动解读 | 百济神州盘前大涨5.79%，业绩和核心产品表现优异推动股价上行

百济神州(06160)发布2024年度业绩快报营业总收入272.14亿元同比增加56.2%

百济神州2024年营收272.14亿元，净亏损同比收窄

百济神州审计委员会主席变更 Shalini Sharp接任

百济神州(06160)2024全年业绩取得强劲增长，全球总收入达38.1亿美元，同比增长55%

百济神州(06160)首次给予财务指引：2025年预计实现经营利润为正

百济神州2024营收增长56.2%，全球研发加速推进 | 财报见闻

华尔街见闻

百济神州2025年营业收入预计约为352亿元至381亿元

百济神州预计2025年营收352亿元至381亿元毛利率达80%-90%

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/ONC/news?page=7"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"百济神州","latestPrice":230.98,"timestamp":1744920000000,"preClose":228.14,"halted":0,"volume":519865,"hourTrading":{"tag":"盘后","latestPrice":229.75,"preClose":230.765,"latestTime":"17:21 EDT","volume":54100,"amount":12495855.13,"timestamp":1744924915084},"delay":0,"floatShares":79387510,"shares":107719405,"eps":-6.124009,"marketStatus":"休市中","change":2.84,"latestTime":"04-17 16:00:00 EDT","open":229.3,"high":234.15,"low":227.3961,"amount":119885584.17555,"amplitude":0.029604,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-6.124009,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":228.14,"preHourTrading":{"tag":"盘前","latestPrice":233.81,"preClose":228.14,"latestTime":"08:41 EDT","volume":73,"amount":17065.739250000002,"timestamp":1744893686762},"postHourTrading":{"tag":"盘后","latestPrice":229.75,"preClose":230.765,"latestTime":"17:21 EDT","volume":54100,"amount":12495855.13,"timestamp":1744924915084},"volumeRatio":0.7116059393545304,"impliedVol":0.529,"impliedVolPercentile":0.8767},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":79387510,"roa":"-6.07%","roe":"-18.77%","lyrEps":-6.124009,"volumeRatio":0.7116059393545304,"shares":107719405,"dividePrice":0,"high":234.15,"amplitude":0.029604,"preClose":228.14,"low":227.3961,"week52Low":126.9681,"pbRate":"7.47","psRate":"6.53","week52High":287.88,"institutionHeld":0,"latestPrice":230.98,"eps":-6.124009,"divideRate":0,"volume":519865,"delay":0,"ttmEps":-6.124009,"open":229.3,"prevYearClose":184.71,"prevWeekClose":230.36,"prevMonthClose":272.17,"prevQuarterClose":272.17,"fiveDayClose":208.31,"twentyDayClose":262.59,"sixtyDayClose":222.22,"earningDate":1746547200000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:7,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2514365291","title":"【港股异动丨百济神州逆势高开超5%再创逾2年新高，预计2025年实现经营利润为正】百济神州(6160.HK)逆势高开5.2%，报170港元，股价创2023年1月以来新高。 百济神州昨晚公布2024年度财报，按美国公认会计准(GAAP)，总收入38.1亿美元，同比增加55%，主要受惠百悦泽在美国和欧洲的销售额增长。GAAP经营亏损由12.08亿美元，收窄至5.68亿美元；实现全年非GAAP经营利润4,536万美元。2025年，收入指引介乎49亿至53亿美元；GAAP经营费用41亿至44亿美元；GAAP毛利率将处于80%-90%的中位区间。同时，重申GAAP经营利润为正，且经营活动产生现金流为正。 TD Cowen维持百济神州买入评级，并将美股目标价从260美元上调至334美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2514365291","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514365291?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 09:24","pubTimestamp":1740705888,"startTime":"0","endTime":"0","summary":"百济神州昨晚公布2024年度财报，按美国公认会计准，总收入38.1亿美元，同比增加55%，主要受惠百悦泽在美国和欧洲的销售额增长。GAAP经营亏损由12.08亿美元，收窄至5.68亿美元；实现全年非GAAP经营利润4,536万美元。2025年，收入指引介乎49亿至53亿美元；GAAP经营费用41亿至44亿美元；GAAP毛利率将处于80%-90%的中位区间。同时，重申GAAP经营利润为正，且经营活动产生现金流为正。TD Cowen维持百济神州买入评级，并将美股目标价从260美元上调至334美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/28092448445685.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["06160","159399","ONC","TD","688235"],"gpt_icon":0},{"id":"2514689723","title":"百济神州发布2024年度业绩快报 营业总收入272.14亿元同比增加56.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514689723","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514689723?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 08:42","pubTimestamp":1740703320,"startTime":"0","endTime":"0","summary":"　　百济神州发布2024年度业绩快报，营业总收入272.14亿元，同比增加56.2%；归属于母公司所有者的净亏损49.78亿元，同比收窄25.87%；基本每股亏损3.64元。　　公告称，营业收入增加主要得益于百悦泽 ，以及安进授权产品和百泽安的销售增长。　　2024年，百悦泽全球销售额总计188.59亿元，同比增长106.4%，在血液肿瘤领域进一步巩固领导地位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-28/doc-inemyxcp7159864.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1161","LU0588546209.SGD","06160","BK1583","BK1500","688235","BK4139","BK0239","LU0307460666.USD","LU1969619763.USD","LU2328871848.SGD","BK1588","ONC"],"gpt_icon":0},{"id":"2514350322","title":"百济神州，正在走安进曾经的路","url":"https://stock-news.laohu8.com/highlight/detail?id=2514350322","media":"医曜","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514350322?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 07:28","pubTimestamp":1740698880,"startTime":"0","endTime":"0","summary":"随着百济神州2024年财报的披露，其再次向市场深化了“创新药一哥”的定位。无论是市值规模，还是产品成熟度，百济神州显然与安进都不是一个等级的对手，简单静态对比并不能得出什么有效结论。如果以此视角推测，虽然不能说百济神州估值过高，但也应警惕如当年安进估值回落盘整的风险。如果说百济神州正在走安进曾经的路，那么长达十二年的潜在瓶颈期才是最考验投资者认知的。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808161998958181&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022808161998958181&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1057294990.SGD","IE0009355771.USD","LU0122379950.USD","LU2242652126.USD","LU0109394709.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","BK4585","IE00BJT1NW94.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU1571399168.USD","LU0058720904.USD","LU2242646821.SGD","BK4599","LU1061106388.HKD","06160","LU0320765992.SGD","LU1023059063.AUD","SG9999001440.SGD","BK4588","LU2112291526.USD","BK4533","LU0889565916.HKD","BK4566","IE00BFTCPJ56.SGD","BK4534","BK4139","LU0868494617.USD","AMGN","BK4581","LU0289739699.SGD","ONC","LU1983299246.USD"],"gpt_icon":0},{"id":"2514354636","title":"百济神州预计2025年实现经营利润为正 创新药企回暖在即？","url":"https://stock-news.laohu8.com/highlight/detail?id=2514354636","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514354636?lang=zh_cn&edition=fundamental","pubTime":"2025-02-28 07:15","pubTimestamp":1740698127,"startTime":"0","endTime":"0","summary":"【百济神州预计2025年实现经营利润为正 创新药企回暖在即？】2月27日晚间，百济神州发布了2024年第四季度及全年的财务业绩，同时发布A股业绩快报公告。财报显示，百济神州2024年在全球市场持续展示出强劲的增长势头，全年总收入达38亿美元，同比增长55%。产品收入成为推动营收增长的主要动力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1354,202502283332138871.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202502283332138871.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["ONC","06160","LU1969619763.USD","BK1500","BK1574","LU2328871848.SGD","LU0307460666.USD","BK1161","BK1588","BK1583","159992","06978","688235","BK0239","LU0588546209.SGD","BK4139"],"gpt_icon":0},{"id":"1163418084","title":"异动解读 | 百济神州核心产品表现出色 公司2025年营收利润预期向好推动股价大涨6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1163418084","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163418084?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 23:58","pubTimestamp":1740671936,"startTime":"0","endTime":"0","summary":"2月27日周四盘中,百济神州股价大涨6.04%,引发了市场的广泛关注。百济神州公布2024年全年业绩显著向好,其核心产品百悦泽和百泽安销售实现大幅增长。据公告,2024年百悦泽全球销售额达到188.59亿元人民币,同比大增106.4%。随着核心产品销售持续放量,百济神州去年营业收入大增56.2%至272.14亿元。公司预计2025年营业收入将介于352亿至381亿元之间,同时经营利润和现金流也将转正。这一良好的经营预期推动了百济神州股价今日大涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ONC"],"gpt_icon":0},{"id":"2514384468","title":"百济神州2024年度亏损近50亿元 美国市场首次贡献超50%收入","url":"https://stock-news.laohu8.com/highlight/detail?id=2514384468","media":"每日经济新闻","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514384468?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 23:53","pubTimestamp":1740671609,"startTime":"0","endTime":"0","summary":"2月27日晚间，百济神州美股发布了2024年第四季度及全年的财务业绩，同时发布了A股业绩快报公告。业绩快报显示，公司产品收入为269.94亿元，较上年同比上升74.1%；营业总收入为272.14亿元，较上年同比上升56.2%；归属于母公司所有者的净利润为亏损49.78亿元，较上年同比收窄25.87%。值得注意的是，今年对于百济神州是一个关键的转折点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502273332051620.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273332051620.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1500","BK1583","BK4139","ONC","BK1588","LU0307460666.USD","LU1969619763.USD","LU0588546209.SGD","06160","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514811953","title":"百济神州(688235.SH)2024年度营收上升56.2%至272.14亿元，产品销售增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2514811953","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514811953?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 23:32","pubTimestamp":1740670352,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(688235.SH)披露2024年度业绩快报，公司营业总收入为272.14亿元，较上年同比上升56.2%;报告期内，公司归属于母公司所有者的净亏损49.78亿元。2024年，产品收入为269.94亿元，上年同期产品收入为155.04亿元，产品收入的增长主要得益于百悦泽®(泽布替尼胶囊)，以及安进授权产品和百泽安®(替雷利珠单抗)的销售增长。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255831.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06160","688235","ONC"],"gpt_icon":0},{"id":"2514138506","title":"正在向盈利冲刺的百济神州，2024年经调整的营业利润提前转正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514138506","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514138506?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 22:49","pubTimestamp":1740667798,"startTime":"0","endTime":"0","summary":"已诞生出“10亿美元分子”的百济神州（ONC.NS、06160.HK、688235.SH）何时能实现盈利，是市场关注的焦点。2月27日晚间，百济神州发布的业绩快报显示，2024年，公司经调整的营业利润指标（包含投资收益及其他收益等）已提前转正，这是公司首次在年度经调整的营业利润指标上转正。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502273332014697.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273332014697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","BK1588","BK1161","LU0588546209.SGD","LU1969619763.USD","ONC","BK1583","06160","BK4139","LU0307460666.USD","LU2328871848.SGD"],"gpt_icon":0},{"id":"2514800789","title":"百济神州去年净亏收窄至近50亿元，首次给出财务指引料今年经营利润转正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514800789","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514800789?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 22:04","pubTimestamp":1740665040,"startTime":"0","endTime":"0","summary":"A股市值刚刚超越恒瑞医药的百济神州交出了2024年成绩单，还首次给出业绩指引。归母净亏损收窄至49.78亿元，归母扣非净亏损收窄至53.79亿元。百济神州还首次给予财务指引，2025年全年总收入指引为49亿至53亿美元，其中包括收入强劲增长的预期，受益于百悦泽在美国的领先地位以及在欧洲和全球其他重要市场的持续扩张。2月21日，百济神州A股市值首次超越国内医药行业“老大哥”恒瑞医药，被行业视为“历史性时刻”。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722054998950a01&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022722054998950a01&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688235","BK4139","ONC"],"gpt_icon":0},{"id":"2514027708","title":"百济神州2024年净亏损近50亿元 同比减亏25.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514027708","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514027708?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:12","pubTimestamp":1740661928,"startTime":"0","endTime":"0","summary":"2月27日，百济神州（688235.SH，股价226元，市值3135.45亿元）发布2024年业绩快报，去年公司产品收入为269.94亿元，较上年同比上升74.1%；营业总收入为272.14亿元，较上年同比上升56.2%；归属于母公司所有者的净利润为-49.78亿元，同比收窄25.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502273331948936.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331948936.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","LU0588546209.SGD","BK1583","06160","BK1500","BK4139","LU0307460666.USD","LU1969619763.USD","LU2328871848.SGD","BK1588","ONC"],"gpt_icon":0},{"id":"2514804534","title":"百济神州(06160)：Shalini Sharp获委任为董事会审计委员会主席","url":"https://stock-news.laohu8.com/highlight/detail?id=2514804534","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514804534?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:03","pubTimestamp":1740661417,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州(06160)发布公告，自2025年3月1日起，Shalini Sharp获委任为董事会审计委员会主席。Anthony C. Hooper不再担任审计委员会主席，但将继续担任审计委员会成员。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255657.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","LU2328871848.SGD","688235","LU1969619763.USD","ONC","BK0239","BK4139","LU0307460666.USD","LU0588546209.SGD","06160","BK1500","BK1583","BK1161"],"gpt_icon":0},{"id":"1139584449","title":"异动解读 | 百济神州盘前大涨5.79%，业绩和核心产品表现优异推动股价上行","url":"https://stock-news.laohu8.com/highlight/detail?id=1139584449","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139584449?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661252,"startTime":"0","endTime":"0","summary":"2月27日周四,百济神州在盘前交易中大涨5.79%,股价上涨引发了市场的广泛关注。从最新财报来看,该公司业绩表现优异,核心产品销售额快速攀升,这些有力因素共同推动了股价的大幅上行。百济神州自主研发的核心产品之一百悦泽取得了令人瞩目的销售成绩。百悦泽已获批多个适应症,在治疗血液肿瘤领域具有领先优势。此外公司在多个新产品的研发进展顺利,有望进一步提升竞争力和盈利能力。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["ONC"],"gpt_icon":0},{"id":"2514802336","title":"百济神州(06160)发布2024年度业绩快报 营业总收入272.14亿元 同比增加56.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514802336","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514802336?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 21:00","pubTimestamp":1740661230,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 发布2024年度业绩快报，营业总收入272.14亿元，同比增加56.2%;归属于母公司所有者的净亏损49.78亿元，同比收窄25.87%;基本每股亏损3.64元。2024年，百悦泽全球销售额总计188.59亿元，同比增长106.4%，在血液肿瘤领域进一步巩固领导地位。中国销售额总计18.56亿元，同比增长35.2%，主要得益于该产品在已获批适应症领域的销售增长。2024年，百泽安的销售额总计44.67亿元，同比增长17.4%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255652.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ONC","688235","LU0588546209.SGD","LU0307460666.USD","LU1969619763.USD","BK0239","BK1583","06160","BK1500","BK1161","BK4139","LU2328871848.SGD","BK1588"],"gpt_icon":0},{"id":"2514645801","title":"百济神州2024年营收272.14亿元，净亏损同比收窄","url":"https://stock-news.laohu8.com/highlight/detail?id=2514645801","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514645801?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 20:29","pubTimestamp":1740659398,"startTime":"0","endTime":"0","summary":"北京商报讯（记者王寅浩）2月27日，百济神州发布2024年度业绩快报。公告显示，百济神州2024年实现营业总收入272.14亿元，同比增长56.2%；净利润亏损49.78亿元，上年同期亏损67.16亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502273331918345.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331918345.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","06160"],"gpt_icon":0},{"id":"2514580631","title":"百济神州审计委员会主席变更 Shalini Sharp接任","url":"https://stock-news.laohu8.com/highlight/detail?id=2514580631","media":"财中社","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514580631?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 20:08","pubTimestamp":1740658102,"startTime":"0","endTime":"0","summary":"2月27日，百济神州（688235/06160/BGNE）发布公告，董事会审计委员会主席发生变更。自2025年3月1日起，ShaliniSharp被委任为审计委员会主席，AnthonyC.Hooper不再担任此职务，但仍将继续作为审计委员会成员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331889469.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1500","06160","LU0588546209.SGD","ONC","BK1588","BK1583","LU1969619763.USD","BK4139","BK1161","LU2328871848.SGD","LU0307460666.USD"],"gpt_icon":0},{"id":"2514805793","title":"百济神州(06160)2024全年业绩取得强劲增长，全球总收入达38.1亿美元，同比增长55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514805793","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514805793?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 20:01","pubTimestamp":1740657709,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百济神州 公布2024年第四季度和全年财务业绩，于2024年第四季度，公司全球总收入达11.28亿美元，同比增长78%，经调整经营利润7860.3万美元，同比扭亏为盈，GAAP研发费用5.42亿美元，同比增长10%;于2024年全年，公司全球总收入达38.1亿美元，同比增长55%;经调整经营利润4535.6万美元，同比扭亏为盈;GAAP经营亏损持续收窄，实现全年非GAAP经营利润为正;GAAP研发费用19.53亿美元，同比增长10%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255578.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4139","LU0588546209.SGD","LU1969619763.USD","BK1588","BK1500","LU2328871848.SGD","BK1583","LU0307460666.USD","ONC","06160","BK1161","688235"],"gpt_icon":0},{"id":"2514180341","title":"百济神州(06160)首次给予财务指引：2025年预计实现经营利润为正","url":"https://stock-news.laohu8.com/highlight/detail?id=2514180341","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514180341?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 19:55","pubTimestamp":1740657329,"startTime":"0","endTime":"0","summary":"报告期内，百济神州经营亏损显著收窄，同时，去除股份支付费用、折旧及摊销费用等非现金项目影响后，实现全年非GAAP经营利润为正。值得一提的是，百济神州首次给予财务指引，2025年全年总收入指引为49亿至53亿美元，其中包括收入强劲增长的预期，受益于百悦泽在美国的领先地位以及在欧洲和全球其他重要市场的持续扩张。同时，公司重申预计GAAP经营利润为正且经营活动产生现金流为正。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1255572.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK4139","LU0588546209.SGD","LU1969619763.USD","BK1588","BK1500","LU2328871848.SGD","BK1583","LU0307460666.USD","ONC","06160","BK1161","688235"],"gpt_icon":0},{"id":"2514808724","title":"百济神州2024营收增长56.2%，全球研发加速推进 | 财报见闻","url":"https://stock-news.laohu8.com/highlight/detail?id=2514808724","media":"华尔街见闻","labels":["viewpoints"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514808724?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 19:45","pubTimestamp":1740656747,"startTime":"0","endTime":"0","summary":"得益于核心产品百悦泽（泽布替尼胶囊）和百泽安（替雷利珠单抗）的销售增长，百济神州2024年度营业总收入达到272.14亿元人民币，亏损较上年同期有所收窄。","market":"hk","thumbnail":"https://wpimg-wscn.awtmt.com/521f1804-36c1-4e49-b75d-11357d3c744f.jpeg","type":0,"news_type":0,"thumbnails":["https://wpimg-wscn.awtmt.com/521f1804-36c1-4e49-b75d-11357d3c744f.jpeg"],"rights":{"source":"wallstreetcn_hot_news","url":"https://wallstreetcn.com/articles/3742046","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3742046","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"百济神州2024营收增长56.2%，全球研发加速推进 | 财报见闻","news_tag":"viewpoints","news_rank":0,"length":0,"strategy_id":0,"source":"wallstreetcn_hot_news","symbols":["06160","ONC"],"gpt_icon":1},{"id":"2514542803","title":"百济神州2025年营业收入预计约为352亿元至381亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514542803","media":"北京商报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514542803?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 19:36","pubTimestamp":1740656174,"startTime":"0","endTime":"0","summary":"北京商报讯（记者丁宁）2月27日晚间，百济神州(688235)发布公告称，2025年营业收入预计将介于352亿元至381亿元之间。收入强劲增长的预期主要受益于百悦泽在美国的领先地位以及在欧洲和全球其他重要市场的持续扩张；同时基于公司产品组合和生产效率的提高，预计2025年毛利率将处于80%至90%的中位区间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202502273331857755.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331857755.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","06160"],"gpt_icon":0},{"id":"2514870075","title":"百济神州预计2025年营收352亿元至381亿元 毛利率达80%-90%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514870075","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2514870075?lang=zh_cn&edition=fundamental","pubTime":"2025-02-27 19:27","pubTimestamp":1740655624,"startTime":"0","endTime":"0","summary":"2月27日，百济神州（688235/06160/BGNE）发布公告，预计2025年度营业收入将在352亿元至381亿元之间，主要得益于其产品在美国的领先地位及在欧洲和其他市场的持续扩张。同时，预计年毛利率将处于80%至90%的中位区间。公司计划继续增加对商业化及研发的投入，预计2025年研发费用、销售及管理费用合计将介于295亿元至319亿元之间。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202502273331846312.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["ONC","06160"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"date":"2025-05-07","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":-0.74,"defaultRemindTime":1746604800000,"name":null,"time":"盘前","dateTimestamp":1746590400000,"actualEps":null},{"market":"US","date":"2025-02-27","symbol":"ONC","fiscalQuarterEnding":"2024/12","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":-1.43},{"market":"US","date":"2024-11-12","symbol":"ONC","fiscalQuarterEnding":"2024/09","expectedEps":-0.88,"name":null,"time":"盘前","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-08-07","symbol":"ONC","fiscalQuarterEnding":"2024/06","expectedEps":-2.1,"name":null,"time":"盘前","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"pre","actualEps":-1.15},{"market":"US","date":"2024-05-11","symbol":"ONC","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715400000000,"reportTimeType":"post","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.6818,"hold":0.0455,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6818,"analysts":22,"updateTime":1744084800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2025-04-17","current":-38.113584,"percent":0.422535,"low":-46.072488,"twenty":-42.748137,"median":-33.549429,"eighty":-28.784295,"high":-22.805663,"avg":-34.842528,"sd":7.324243,"marketCap":24575105056},"quantilePoints":[{"date":"2025-01-03","current":-23.85925,"twenty":-23.85925,"median":-23.85925,"eighty":-23.85925,"marketCap":19590153584},{"date":"2025-01-10","current":-23.169003,"twenty":-23.588216,"median":-23.51181,"eighty":-23.096335,"marketCap":18938568040},{"date":"2025-01-17","current":-26.770744,"twenty":-26.217794,"median":-23.689854,"eighty":-23.142836,"marketCap":21882666138},{"date":"2025-01-24","current":-28.798988,"twenty":-27.60701,"median":-25.13119,"eighty":-23.374687,"marketCap":23683664763},{"date":"2025-01-31","current":-29.253094,"twenty":-28.895055,"median":-26.770744,"eighty":-23.516999,"marketCap":24179205805},{"date":"2025-02-07","current":-29.699946,"twenty":-29.114029,"median":-28.456686,"eighty":-23.723733,"marketCap":24422582437},{"date":"2025-02-14","current":-29.279798,"twenty":-29.132261,"median":-28.781271,"eighty":-23.9826,"marketCap":24061904635},{"date":"2025-02-21","current":-31.546239,"twenty":-29.269116,"median":-28.798062,"eighty":-24.917918,"marketCap":26058437677},{"date":"2025-02-28","current":-46.072488,"twenty":-30.312806,"median":-28.916244,"eighty":-26.238043,"marketCap":29706894943},{"date":"2025-03-07","current":-42.702936,"twenty":-33.205878,"median":-29.060335,"eighty":-26.487572,"marketCap":27534255325},{"date":"2025-03-14","current":-42.304107,"twenty":-40.627279,"median":-29.228112,"eighty":-26.926934,"marketCap":27277096074},{"date":"2025-03-21","current":-43.63686,"twenty":-41.989697,"median":-29.279798,"eighty":-27.60701,"marketCap":28136436571},{"date":"2025-03-28","current":-43.795471,"twenty":-42.273573,"median":-29.808923,"eighty":-28.393975,"marketCap":28238706493},{"date":"2025-04-04","current":-44.082326,"twenty":-43.290212,"median":-30.877376,"eighty":-28.597906,"marketCap":28423666794},{"date":"2025-04-11","current":-34.741183,"twenty":-42.946887,"median":-33.164233,"eighty":-28.695114,"marketCap":22400628140},{"date":"2025-04-17","current":-38.113584,"twenty":-42.748137,"median":-33.549429,"eighty":-28.784295,"marketCap":24575105056}],"updateTime":1745134919326}}}